Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Monoclonal MRP1 Primary Antibody for CyTOF, ELISA - ABIN268892
Chen, Yang, Liu, Han, Zhang: Cytoplasmic retraction of the amino terminus of human multidrug resistance protein 1. in Biochemistry 2002
Show all 10 Pubmed References
Human Polyclonal MRP1 Primary Antibody for IF (p), IHC (p) - ABIN671526
Hu, Peng, Li: The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer. in Journal of experimental & clinical cancer research : CR 2009
Show all 3 Pubmed References
Human Monoclonal MRP1 Primary Antibody for ICS - ABIN2689852
Hipfner, Gauldie, Deeley, Cole: Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. in Cancer research 1994
Show all 2 Pubmed References
Human Polyclonal MRP1 Primary Antibody for IHC, ELISA - ABIN1584832
Park, Kubicki, Gnyawali, Chan, Roy, Khanna, Sen: Natural vitamin E ?-tocotrienol protects against ischemic stroke by induction of multidrug resistance-associated protein 1. in Stroke; a journal of cerebral circulation 2011
Human Monoclonal MRP1 Primary Antibody for ICC, IF - ABIN189465
Chen, Yang, Li, Zhang: The amino terminus of the human multidrug resistance transporter ABCC1 has a U-shaped folding with a gating function. in The Journal of biological chemistry 2006
Human Monoclonal MRP1 Primary Antibody for FACS, IHC (fro) - ABIN445905
Kurihara, Sawazumi, Takeuchi: Exploration of interactions between membrane proteins embedded in supported lipid bilayers and their antibodies by reflectometric interference spectroscopy-based sensing. in The Analyst 2014
CD9 (show CD9 Antibodies) stabilizes gp130 (show IL6ST Antibodies) by blocking its ubiquitin-dependent lysosomal degradation to promote the IL6 (show IL6 Antibodies)-gp130 (show IL6ST Antibodies)-bone marrow X-linked non-receptor tyrosine kinase (show TNK1 Antibodies)-STAT3 (show STAT3 Antibodies) signaling for maintaining GSC (show GSC Antibodies) selfrenewal and tumorigenic capacity.
CD9 (show CD9 Antibodies) was highly expressed on extravillous trophoblast (EVT) at the boundary region of EVT invasion and intravascular EVT. CD9 (show CD9 Antibodies) expression on Swan71 cells was reduced under hypoxic conditions, while its expression was increased by co-culture with HUVEC. CD9 (show CD9 Antibodies) could attenuate EVT invasion under the influence of an oxygen environment and maternal endothelial cells, proposing CD9 (show CD9 Antibodies) as a potential regulator of human placentation.
As for 18Lin(-), CD34 (show CD34 Antibodies)(-) HSCs are characterized by low expression of the tetraspanin CD9 (show CD9 Antibodies), which promotes homing, and high expression of the peptidase CD26 (show DPP4 Antibodies), which inhibits homing.
The findings suggest that, in contrast with previous models, the ligand-binding site of integrin alphaVbeta3 (show ITGAV Antibodies), binds to the constant region (helices A and B) of the EC2 (show TCF15 Antibodies) domain of CD9 (show CD9 Antibodies), CD81 (show CD81 Antibodies), and CD151 (show CD151 Antibodies) antigens.
Data suggest that CD9 (show CD9 Antibodies) should be further evaluated as a target for glioblastoma treatment.
Collectively, using tetraspanin CD9 (show CD9 Antibodies) in tandem with E-cadherin (show CDH1 Antibodies) as a biomarker in renal cell carcinoma (show MOK Antibodies) will help to not only distinguish between types, but also predict the metastatic potential of RCC (show XRCC1 Antibodies).
Data indicate that CD9 (show CD9 Antibodies) is implicated in BCC invasiveness and metastases by cellular mechanisms that involve specific CD9 (show CD9 Antibodies)+ plasma membrane protrusions of BCCs.
CD9 (show CD9 Antibodies)-enriched microdomains negatively regulate LPS (show IRF6 Antibodies)-induced receptor formation by preventing CD14 (show NDUFA2 Antibodies) from accumulating into lipid rafts. [Review]
Results indicate that CD9 (show CD9 Antibodies) downregulation promoted pancreatic cancer cell proliferation and migration through at least in part, enhancing the cell surface expression of EGFR (show EGFR Antibodies).
CD9 (show CD9 Antibodies) expression is upregulated and its expression is correlated with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma patients
Mice lacking RXRalpha (show RXRA Antibodies) in myeloid cells exhibit reduced levels of CCL6 (show CCL6 Antibodies) and CCL9 (show Ccl9 Antibodies), impaired recruitment of leukocytes to sites of inflammation, and lower susceptibility to sepsis.
enhanced expression in intestinal epithelium following immunostimulation with LPS (show TLR4 Antibodies) or pro-inflammatory cytokines
the injury-induced expression of C10 (show C12orf57 Antibodies) at the mRNA and protein level
c10 (show C12orf57 Antibodies) promotes fibrosis by recruiting macrophages in the inflammatory response to bleomycin in the lung
CCL6 (show CCL6 Antibodies) gene activation and production induced by SCF (show KITLG Antibodies) in the presence or absence of rather specific inhibitors for certain pathways demonstrated that the MEK (show MDK Antibodies)/MAPK (show MAPK1 Antibodies) pathway but not the PI-3K pathway was crucial for the SCF (show KITLG Antibodies)-induced CCL6 (show CCL6 Antibodies) gene activation.
the chemokines CCL6 (show CCL6 Antibodies) and CCL9 (show Ccl9 Antibodies) as genes prominently induced by the type I IFNs and ICSBP (show IRF8 Antibodies)
This gene encodes a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Tetraspanins are cell surface glycoproteins with four transmembrane domains that form multimeric complexes with other cell surface proteins. The encoded protein functions in many cellular processes including differentiation, adhesion, and signal transduction, and expression of this gene plays a critical role in the suppression of cancer cell motility and metastasis.
ATP-binding cassette sub-family C ( CFTR/MRP) member 1a
, ATP-binding cassette sub-family C member 1
, ATP-binding cassette, sub-family C (CFTR/MRP), member 1
, LTC4 transporter
, leukotriene C(4) transporter
, multidrug resistance protein 1
, multidrug resistance-associated protein 1
, multiple drug resistance-associated protein
, 5H9 antigen
, BA-2/p24 antigen
, CD9 antigen
, CD9 antigen (p24)
, cell growth-inhibiting gene 2 protein
, leukocyte antigen MIC3
, motility related protein-1
, C-C motif chemokine 6
, CC chemokine C10
, small inducible cytokine A6
, small-inducible cytokine A6